LSBCF (LakeShore Biopharma Co) Total Debt per Share: $2.75 (As of Mar. 2025)


What is LakeShore Biopharma Co Total Debt per Share?

LakeShore Biopharma Co LSBCF Total Debt per Share is $2.75 as of Mar. 2025.

$2.75 (As of Mar. 2025)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. LakeShore Biopharma Co's Total Debt Per Share for the quarter that ended in Mar. 2025 was $2.75.

LakeShore Biopharma Co Total Debt per Share Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Total Debt per Share Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Total Debt per Share
0.31 6.51 7.78 3.10 2.75

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Total Debt per Share Get a 7-Day Free Trial Premium Member Only 7.78 8.16 3.10 2.73 2.75

LakeShore Biopharma Co Total Debt per Share Calculation

LakeShore Biopharma Co's Total Debt Per Share for the fiscal year that ended in Mar. 2025 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(3.24+53.92)/20.77
=2.75

LakeShore Biopharma Co's Total Debt Per Share for the quarter that ended in Mar. 2025 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(3.24+53.92)/20.77
=2.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of $2.75 mean?
LakeShore Biopharma Co (LSBCF) has a Total Debt per Share of $2.75 as of Mar. 2025. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Total Debt per Share too high?
LakeShore Biopharma Co's current Total Debt per Share is $2.75.
How does LakeShore Biopharma Co's Total Debt per Share compare to ACUT and PPCB?
LakeShore Biopharma Co's Total Debt per Share of $2.75 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Biotechnology company?
A good Total Debt per Share depends on the Biotechnology industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Total Debt per Share is $2.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Total Debt per Share of $2.75. The current Total Debt per Share is $2.75. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Total Debt per Share is $2.75 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.